LHPP in glutamatergic neurons of the ventral hippocampus mediates depression-like behavior by dephosphorylating CaMKIIα and ERK

Lvping Zhuang,Weijie Gao,Yanbing Chen,Wenting Fang,Hsuan Lo,Xiaoman Dai,Jie Zhang,Wanjing Chen,Qinyong Ye,Xiaochun Chen,Jing Zhang
DOI: https://doi.org/10.1016/j.biopsych.2023.08.026
IF: 12.81
2023-09-01
Biological Psychiatry
Abstract:BACKGROUND: Phospholysine phosphohistidine inorganic pyrophosphate phosphatase (LHPP) was recently shown to be a risk gene for major depressive disorder (MDD). LHPP has been proven to dephosphorylate the residues of histidine, serine, threonine, and tyrosine. However, much remains unknown regarding how LHPP contributes to depression.METHODS: The present study addressed this issue by integrating approaches of genetics, molecular biology, behavioral testing and electrophysiology.RESULTS: We have discovered here that the levels of LHPP was upregulated in the glutamatergic neurons of the ventral hippocampus (vHip) in mice that displayed stress-induced depression-like behaviors. The knockout of LHPP in glutamatergic neurons of the brain improved the spontaneous activity of LHPP<sup>flox/flox</sup>·CaMKIIαCre+ (cKO) mice. Adeno-associated virus-mediated LHPP knockdown in the vHip enhanced resistance against chronic social defeat stress (CSDS) in mice. Manipulations of LHPP levels impacted the density of dendritic spines and excitability of CA1 pyramidal neurons by mediating the expressions of BDNF and PSD95 via the modulation of the dephosphorylation of Calcium-calmodulin (CaM)-dependent protein kinase II α (CaMKIIα) and extracellular signal-regulated kinase (ERK). Notably, compared with wild-type LHPP, human mutant LHPP (E56K, S57L) significantly increased the activity of the CaMKIIα/ERK-BDNF/PSD95 signaling pathway. Finally, esketamine, not fluoxetine, markedly alleviated the LHPP-upregulation-induced depression-like behaviors.CONCLUSIONS: These findings show evidence that LHPP contributes to the pathogenesis of depression via threonine and serine hydrolases, signifying LHPP as a potential therapeutic target in treating MDD patients.
neurosciences,psychiatry
What problem does this paper attempt to address?